194 related articles for article (PubMed ID: 35152510)
21. A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.
Lin L; Li S; Xiong Q; Wang H
BMC Pulm Med; 2021 Mar; 21(1):95. PubMed ID: 33740937
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
23. Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion.
Huang JH; Chen H; Zhang ZC; Gu J; Yan L; Jiang MP; Zheng WQ; Hu ZD; Jiang TW
BMC Pulm Med; 2023 Jun; 23(1):198. PubMed ID: 37286973
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis.
Cheng C; Yang Y; Yang W; Wang D; Yao C
Expert Rev Respir Med; 2022 Jan; 16(1):99-108. PubMed ID: 34112035
[TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminase-based measurement in the differential diagnosis of pleural effusion: a multicenter retrospective study.
Gao L; Wang W; Zhang Y; Hu X; An J; Li Y; Chen M; Shen Y
Ther Adv Respir Dis; 2023; 17():17534666231155747. PubMed ID: 36846945
[TBL] [Abstract][Full Text] [Related]
26. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
Li R; Gao Z; Dong K; Wang H; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
[TBL] [Abstract][Full Text] [Related]
27. Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.
Wang K; Hu X; Chen Y; Yi X; Han X; Zhu D; Zhu B; Luo H
Clin Respir J; 2024 Jan; 18(1):e13705. PubMed ID: 37775991
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
31. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
32. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion.
Rabbi MF; Ahmed MN; Patowary MSA; Huq SR; Razzaque SMA; Arafat HM; Nahar T; Iktidar MA
BMC Pulm Med; 2023 Sep; 23(1):349. PubMed ID: 37715196
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
Xu CH; Hao KK; Yu LK; Zhang XW
Asia Pac J Clin Oncol; 2015 Mar; 11(1):28-33. PubMed ID: 24720371
[TBL] [Abstract][Full Text] [Related]
34. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
35. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing malignant pleural effusion using clinical and analytical parameters.
Pan Y; Bai W; Chen J; Mao Y; Qian X; Xu K; Tang S; Zhang J; Chen C; Chen J; Hu X
J Clin Lab Anal; 2019 Feb; 33(2):e22689. PubMed ID: 30390322
[TBL] [Abstract][Full Text] [Related]
37. Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
Ren Z; Xu L
Clinics (Sao Paulo); 2021; 76():e2515. PubMed ID: 33909825
[TBL] [Abstract][Full Text] [Related]
38. The role of pleural fluid lactate dehydrogenase-to-adenosine deaminase ratio in differentiating the etiology of pleural effusions.
Ho CY; Tsai YH; Chang CC; Huang HL; Tan NC; Chen WC; Leong KI
Chin J Physiol; 2022; 65(3):105-108. PubMed ID: 35775528
[TBL] [Abstract][Full Text] [Related]
39. Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor-related pleural effusion.
Li H; Huang L; Tang H; Zhong N; He J
Clin Respir J; 2017 Nov; 11(6):881-886. PubMed ID: 26662658
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion.
Xue K; Xiong S; Xiong W
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):495-7. PubMed ID: 18060618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
